Kavita Sharma MD, is an Associate Professor of Medicine in Advanced Heart Failure/Transplant Cardiology in the Division of Cardiology at the Johns Hopkins University School of Medicine. She is the Director of the Johns Hopkins Heart Failure with Preserved Ejection Fraction Program. She sees patients at The Johns Hopkins Hospital, downtown campus. A cardiologist specializing in advanced heart failure, her clinical interests include advanced heart failure diagnosis and management, heart transplantation, and mechanical circulatory support including left ventricular assist devices. She has a specialized interest in heart failure with preserved ejection fraction (HFpEF), and directs one of the largest programs in the country dedicated to caring for patients with this condition. She is the principal investigator of numerous clinical and translational trials in HFpEF and leads a team of nurses, research coordinators, and fellows-in-training in this multi-faceted program. She is an invited speaker at national meetings in topic areas covering advanced heart failure and HFpEF. Dr. Sharma is a member of the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. Dr. Sharma is rated as an Elite provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Cardiac Amyloidosis, Heart Transplant, and Fasciotomy.

Dr. Chiadi Ndumele is the Director of Obesity and Cardiometabolic Research, Director of the Heart Failure Prevention Program and Associate Professor of Medicine and Epidemiology in the Division of Cardiology at Johns Hopkins University. Dr. Ndumele is a preventive cardiologist with doctorate level training in epidemiology, who leads a research program related to characterizing the relationship of obesity and cardiometabolic risk factors with the development of cardiovascular disease, with a particular focus on heart failure risk, and to refining strategies for cardiovascular disease prevention. His work additionally addresses the impact of social determinants of health on cardiometabolic risk factors and downstream cardiovascular outcomes. Dr. Ndumele received his M.D. from Harvard University and his Internal Medicine training at Brigham and Women’s Hospital, where he also served as Chief Medical Resident. He subsequently trained in Cardiology at Johns Hopkins University, where he was also Chief Cardiology Fellow in his final year and where he also received his MHS and PhD in Epidemiology. Dr. Ndumele’s research has been supported by multiple grants from the NIH, Robert Wood Johnson Foundation and the American Heart Association (AHA). He is Chair of the Council on Lifestyle and Cardiometabolic Health of the AHA, Past Chair of the AHA Obesity Committee, and Co-Chair of the AHA Cardiovascular-Kidney-Metabolic Health Initiative. Dr. Ndumele is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Atherosclerosis, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Metabolic Syndrome.

Virginia Shalkey Hahn, M.D., is a cardiologist specialized in caring for patients with cardiomyopathy and heart failure. Dr. Hahn received her medical degree from the Perelman School of Medicine at the University of Pennsylvania in 2012. She was a Sarnoff Fellow at Johns Hopkins University School of Medicine. She completed internal medicine residency at the Hospital of the University of Pennsylvania and cardiology/advanced heart failure fellowship at Johns Hopkins Hospital, where she was the Marie-Josée and Henry R Kravis Chief Cardiology Fellow. Dr. Hahn's research is focused on translational studies in heart failure using bioinformatics tools and functional assays. She has won several awards and grants for her research. Dr. Hahn is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Heart Attack, and Apoplexy.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Heart Failure, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Joban Vaishnav is a cardiologist specializing in heart failure in Baltimore, Maryland. Additionally, she is an assistant professor at the Baltimore-based Johns Hopkins University School of Medicine. She has special interest in amyloidosis. Dr. Vaishnav earned her medical degree from St. Louis University School of Medicine. She completed a residency in internal medicine at The Johns Hopkins Hospital, where she also completed fellowships in cardiology and advanced heart failure and transplant cardiology. Dr. Vaishnav is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Cardiac Amyloidosis, Heart Failure, Primary Localized Cutaneous Amyloidosis, Heart Transplant, and Tissue Biopsy.

Jeremy Pollock is a Cardiologist in Towson, Maryland. Dr. Pollock is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Atrial Fibrillation, Heart Attack, and Apoplexy.

Lawrence Jacobs is a Cardiologist in Annapolis, Maryland. Dr. Jacobs is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Atrial Fibrillation, Coronary Heart Disease, and Atherosclerosis.

Benjamin Dubois is a Cardiologist in Pikesville,, Maryland. Dr. Dubois is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Atrial Fibrillation, Heart Failure with Preserved Ejection Fraction (HFpEF), Coronary Heart Disease, Atherosclerosis, and Pacemaker Implantation.

Erik Marshall is a Cardiologist in Elkton, Maryland. Dr. Marshall has been practicing medicine for over 42 years and is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Aortic Valve Stenosis, Dilated Cardiomyopathy (DCM), Cardiomyopathy, Coronary Heart Disease, and Pacemaker Implantation.

Lena Mathews specializes in general cardiology and echocardiography. She received her medical degree from University of Pennsylvania School of Medicine and completed an internal medicine residency at Brigham and Women’s Hospital. She completed fellowships in cardiology and echocardiography at the Johns Hopkins University School of Medicine. Dr. Mathews is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Apoplexy, Heart Attack, Heart Failure with Preserved Ejection Fraction (HFpEF), and Atherosclerosis.

Jerome Fleg is a Cardiologist in Bethesda, Maryland. Dr. Fleg is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Coronary Heart Disease, Acute Coronary Syndrome, and Heart Bypass Surgery.

Christopher Haas, DO, specializes in cardiology and is board certified in cardiovascular disease and interventional cardiology by the American Board of Internal Medicine. He practices at UPMC Heart and Vascular Institute. Dr. Haas completed his medical education at Philadelphia College of Osteopathic Medicine, residency at Naval Hospital San Diego, and fellowship at Naval Hospital San Diego and George Washington University Medical Center. Dr. Haas is rated as a Distinguished provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Heart Attack, Heart Failure with Preserved Ejection Fraction (HFpEF), Angina, Atherectomy, and Heart Bypass Surgery.

Tony Dao, M.D., F.A.C.C., received his medical degree from Eastern Virginia Medical School and completed his residency in internal medicine at Washington Hospital Center, where he also served as Chief Resident. He completed a fellowship program in cardiovascular disease at Georgetown University/Washington Hospital Center. His special interests include clinical cardiovascular disease, congestive heart failure, and nuclear cardiology. Dr. Dao is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Atrial Fibrillation, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, Apoplexy, and Pacemaker Implantation.

Virginia C. Colliver, M.D., is a cardiologist with Johns Hopkins Community Physicians-Heart Care (JHCP) in Bethesda, Maryland. Dr. Colliver is also affiliated with Suburban Hospital and Sibley Memorial Hospital. Dr. Colliver has expertise in general and preventive cardiology, heart disease in women, echocardiography and nuclear cardiology. Dr. Colliver earned her medical degree from the University of Maryland School of Medicine. She completed a residency at University of North Carolina, as well as a fellowship in cardiovascular medicine. Dr. Colliver is a fellow of the American College of Cardiology. Dr. Colliver has been recognized as one of the area’s Top Doctors several times by Washingtonian magazine, as well as Consumers' Checkbook. She received the 2017 Johns Hopkins Medicine Excellence in Service and Professionalism Award for providing great care to her patients and leadership to her JHCP office. Videos 2017 Excellence in Service and Professionalism Award What Young Women Need to Know about their Hearts. Dr. Colliver is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Atrial Fibrillation, Heart Failure with Preserved Ejection Fraction (HFpEF), Atherosclerosis, and Coronary Heart Disease.

Nisha Chandra is a Cardiologist in Belcamp,, Maryland. Dr. Chandra is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top areas of expertise are Cardiac Arrest, Apoplexy, Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Attack, and Pacemaker Implantation.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Dr. Robert Weiss is a Clarence Doodeman professor of cardiology as well as a professor of medicine and radiology at the Johns Hopkins University School of Medicine. Dr. Weiss directs a multi-disciplinary team at Johns Hopkins as well as collaborators at Cedars Sinai Medical Center in Los Angeles are dedicated to identifying the most important clinical, genetic, structural, contractile and metabolic causes of sudden cardiac death as well as the means to reverse the underlying pathology and lower risk. His research interests include energetic consequences and causes of heart failure, predictors of sudden cardiac death, non-invasive magnetic resonance, role of creatine kinase in heart failure, spectroscopy and imaging, coronary endothelial function and small animal cardiovascular imaging. Dr. Weiss received an undergraduate degree in physics form Dickinson College and a medical degree from Pennsylvania State University College of Medicine AOA Hershey Medical Center before joining Johns Hopkins in 1983 as an intern and assistant resident. Dr. Weiss has published extensively and has most recently been awarded a fellowship with the International Society of Magnetic Resonance in Medicine. Dr. Weiss is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Pulmonary Hypertension, Heart Attack, Pulmonary Veno-Occlusive Disease, and Coronary Heart Disease.

Sarah Riley, CRNP is a nurse practitioner in Baltimore, Maryland. She specializes in managing patients diagnosed with heart failure. Her expertise includes managing patients diagnosed with heart failure, cardiac amyloidosis and left ventricular assist device (LVAD). Her research includes managing and improving outcomes for patients diagnosed with heart failure. Research SummarySarah's research consists of managing and improving outcomes for patients diagnosed with heart failure, cardiac amyloidosis and implanted left ventricular assist devices (LVAD). Selected Publications Vaishnav, J., Hubbard, A., Chasler, J., Lepley, D., Cuomo, K., Riley, S., Menzel, K., Fajardo, J., Sharma, K., Judge, D., Russell, S., & Gilotra, N. (2020). Management of Heart Failure in Cardiac Amyloidosis Using An Ambulatory Diuresis Clinic: An Analysis of Safety and Health Care Utilization. Journal of Cardiac Failure, 26 (10): S52. https://doi.org/10.1016/j.cardfail.2020.09.153 Hahn, V. S., Yanek, L. R., Vaishnav, J., Ying, W., Vaidya, D., Lee, Y. Z. J., Riley, S. J., Subramanya, V., Brown, E. E., Hopkins, C. D., Ononogbu, S., Perzel Mandell, K., Halushka, M. K., Steenbergen, C., Rosenberg, A. Z., Tedford, R. J., Judge, D. P., Shah, S. J., Russell, S. D., ... Sharma, K. (2020). Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis. JACC: Heart Failure, 8(9), 712-724. https://doi.org/10.1016/j.jchf.2020.04.007 Umapathi, P., Cuomo, K., Riley, S., Hubbard, A., Menzel, K., Sauer, E., Gilotra, N. (2020). Transforming Ambulatory Heart Failure Care in the COVID-19 Era: Initial Experience From a Heart Failure Disease Management Clinic. Journal of Cardiac Failure, 26 (7), 637-638. https://dx.doi.org/10.1016%2Fj.cardfail.2020.06.003 Cummings, A., Fajardo, J., Cuomo, K., Riley, S., Chambers, J., Menzel, K., Rhodes, P., Fitts, F., Russell, S., Judge, D., & Gilotra, N. (2020). Efficacy of a Nurse Practitioner Managed Outpatient Intravenous Diuresis Clinic to Relieve Recurrent Congestion in Patients with Cardiac Amyloidosis. Heart and Lung, 49 (2) 213-214. https://doi.org/10.1016/j.hrtlng.2020.02.017 Freed, K., Cuomo, K., Hubbard, A., Riley, S., Menzel, K., Klemans, N., Fioretti, R., Aslam, M., Umapathi, P., Choi, C. W., Kilic, A., Florido, R., Sharma, K., Hsu, S., & Gilotra, N. (2019). Management of Heart Failure in Left Ventricular Assist Device (LVAD) Patients Utilizing an Outpatient Diuresis Clinic. Journal of Cardiac Failure, 25:sup8. https://doi.org/10.1016/j.cardfail.2019.07.146. Ms. Riley is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). Her top area of expertise is Heart Failure with Preserved Ejection Fraction (HFpEF).

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Roger Blumenthal is the Kenneth Jay Pollin Professor of Cardiology, professor of medicine and director of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease in Baltimore, Maryland. His principal clinical and research interests involve: 1) strategies to improve cardiovascular risk assessment to identify those adults at elevated risk and those at very low risk of cardiovascular disease and 2) the optimal management of atherosclerotic vascular disease. He is an expert in the pathogenesis, treatment and prevention of atherosclerotic vascular disease. Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. He is on the official national spokesperson panel for the American Heart Association and has co-written more than 600 articles dealing with many aspects of coronary heart disease and atherosclerosis management. An experienced writer, Dr. Blumenthal is on the editorial board of Circulation, Cardiology Today, and The American College of Cardiology and Extended Learning Center. He is a fellow of the American College of Cardiology and the American Heart Association’s Epidemiology and Prevention Council. He was co-editor-in-chief of the textbook Preventive Cardiology – A Companion to Braunwald’s Heart Disease. He received his medical degree from Cornell Medical College, where he was awarded the Weiss Prize for Excellence in Clinical Medicine. He did his internal medicine and cardiology fellowship training at The Johns Hopkins Hospital before joining the Johns Hopkins cardiology faculty. Dr. Blumenthal was the 2019 recipient of the Landon School Anthony Kupka Distinguished Alumnus Award. He was co-chairperson of the 2019 American College of Cardiology/American Heart Guideline on prevention of cardiovascular disease. Dr. Blumenthal is rated as an Advanced provider by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Atherosclerosis, Coronary Heart Disease, Metabolic Syndrome, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.